Premenopausal women and low bone density.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Canadian family physician Medecin de famille canadien

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 16812966PMCID PMC1780157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.

  2005cited by this paper
• Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

  2004cited by this paper
• Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children.

  2004cited by this paper
• Bone densitometry in premenopausal women: synthesis and review.

  2004cited by this paper
• Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.

  2002cited by this paper
• clinical practice guidelines for the diagnosis and management of osteoporosis in Canada

  2002cited by this paper
• Changes in Bone Mineral Density with Age in Men and Women: A Longitudinal Study

  2002cited by this paper
• Fractures Before Menopause: A Red Flag for Physicians

  2002cited by this paper
• Effects of contraceptive use on bone biochemical markers in young women.

  2001cited by this paper
• Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.

  2001cited by this paper
• Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study.

  2001cited by this paper
• Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial

  2000cited by this paper
• Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.

  2000cited by this paper
• Low-dose oral contraceptives and bone mineral density: an evidence-based analysis.

  2000cited by this paper
• Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy

  2000cited by this paper
• Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

  1998cited by this paper
• Urinary Ovarian and Gonadotropin Hormone Levels in Premenopausal Women with Low Bone Mass

  1998cited by this paper
• Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

  1998cited by this paper
• Bone Mineral Density and Its Change in Pre‐ and Perimenopausal White Women: The Michigan Bone Health Study

  1998cited by this paper
• Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.

  1998cited by this paper
• World-wide Projections for Hip Fracture

  1997cited by this paper
• Bone-sparing properties of oral contraceptives.

  1996cited by this paper
• Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances.

  1994cited by this paper
• Radial bone mineral density in pre‐ and perimenopausal women: A prospective study of rates and risk factors for loss

  1992cited by this paper
• Diagnosis of Osteoporosis

  1992cited by this paper
• Body composition, age and femoral bone mass of young adult women.

  1991cited by this paper
• Spinal bone loss and ovulatory disturbances

  1990cited by this paper
• Age and bone mass as predictors of fracture in a prospective study.

  1988cited by this paper
• A COMPREHENSIVE REVIEW OF INJECTABLE CONTRACEPTION WITH SPECIAL EMPHASIS ON DEPOT MEDROXYPROGESTERONE ACETATE

  1981cited by this paper
• Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women.

  1976cited by this paper

• Osteoporosis in premenopausal women.

  2025cites this paper
• Osteoporosis in premenopausal women

  2025cites this paper
• Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices.

  2024cites this paper
• mDIXON-Quant technique diagnostic accuracy for assessing bone mineral density in male adult population

  2023cites this paper
• EVALUATE THE EFFECTIVENESS OF PLANNED TEACHING PROGRAMME ON KNOWLEDGE REGARDING BONE DENSITY INVESTIGATION AND ITS IMPORTANCE IN SELECTED COMMUNITY AREA

  2022cites this paper
• Anorexia nervosa: COVID-19 pandemic period (Review).

  2021cites this paper
• PREVALENCE OF RISK FACTORS FOR OSTEOPOROSIS AMONG FEMALES AGED 35 YEARS AND ABOVE IN SAUDI ARABIA

  2020cites this paper
• Treatments to Prevent Bone Loss in Functional Hypothalamic Amenorrhea: A Systematic Review and Meta-Analysis

  2017cites this paper
• Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid

  2017cites this paper
• Bone model to optimize implant selection in total hip arthroplasty

  2017cites this paper
• Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign

  2016cites this paper
• Predictors of bone mineral density in african-american and caucasian college-aged women.

  2015cites this paper
• Occupational exposure to gasoline vapour inhalation causes secondary dysmenorrhea and depletion in luteal phase estradiol levels of young female adults in South Eastern Nigeria

  2014cites this paper
• Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles.

  2014cites this paper
• A randomized, double-blind, placebo-controlled study to evaluate the effects of alendronate on bone mineral density and bone remodelling in perimenopausal women with low bone mineral density.

  2014cites this paper
• A Study of Factors Influencing the Bone Mineral Density on Premenopausal Women: Using the 2011 Korean National Health and Nutrition Examination Survey Data

  2013cites this paper
• Updated Recommendations for the Diagnosis and Management of Osteoporosis: A Local Perspective

  2011cites this paper
• Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density

  2011cites this paper
• Premature Gonadal Insufficiency

  2011influential citation
• Estrogen-related and other disease diagnoses preceding Parkinson’s disease

  2010cites this paper
• Assessment of bone marrow changes in postmenopausal women with varying bone densities: magnetic resonance spectroscopy and diffusion magnetic resonance imaging.

  2010cites this paper
• INJURY RISKS FOR THE FEMALE ATHLETE

  2010cites this paper
• [Osteoporosis in young individuals].

  2010cites this paper
• Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis.

  2010cites this paper
• Osteoporosis in young individuals

  2010cites this paper
• Individual Trabeculae Segmentation (ITS)–Based Morphological Analysis of High-Resolution Peripheral Quantitative Computed Tomography Images Detects Abnormal Trabecular Plate and Rod Microarchitecture in Premenopausal Women With Idiopathic Osteoporosis

  2010cites this paper
• Clinical Characteristics and Medication Use among Premenopausal Women with Osteoporosis and Low BMD: The Experience of an Osteoporosis Referral Center

  2009cites this paper
• Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset

  2009cites this paper
• Correlation between bone mineral density and body composition in Japanese females aged 18–40 years with low forearm bone mineral density

  2009cites this paper
• Perimenopausal Women's Intended and Actual Behavioral Response to Bone Health Interventions

  2008cites this paper
• What is adequate?

  2006cites this paper
• Clarifying omega-3 fatty acid recommendations.

  2006cites this paper